fast track

Kymera receives FDA fast track designation for KT-333
Kymera receives FDA fast track designation for KT-333
Pharmaceutical Business Review
Kymera Therapeutics
fast track
FDA< KT-333
cutaneous T-cell lymphoma
Flag link:
Merck Gets FDA Fast Track for Efinopegdutide, Previews NASH Data Versus Novo’s Semaglutide
Merck Gets FDA Fast Track for Efinopegdutide, Previews NASH Data Versus Novo’s Semaglutide
BioSpace
Merck
efinopegdutide
FDA
NASH
fast track
Flag link:
Agenus Receives Fast Track Designation for Botensilimab and Balstilimab in Colorectal Cancer
Agenus Receives Fast Track Designation for Botensilimab and Balstilimab in Colorectal Cancer
Yahoo/Businesswire
Agenus
immuno-oncology
fast track
FDA
botensilimab
balstilimab
Flag link:
Prothena leverages Walgreens’ capabilities to accelerate development of Alzheimer’s Drug
Prothena leverages Walgreens’ capabilities to accelerate development of Alzheimer’s Drug
Medical Marketing and Media
Prothena
PRX012
fast track
Walgreens
clinical trials
Flag link:
FDA grants fast track designation to Arrowhead Pharmaceuticals’ ARO-APOC3 to reduce triglycerides
FDA grants fast track designation to Arrowhead Pharmaceuticals’ ARO-APOC3 to reduce triglycerides
Pharmaceutical Business Review
Arrowhead Pharmaceuticals
ARO-APOC3
triglycerides
familial chylomicronemia syndrome
fast track
FDA
Flag link:
FDA grants fast track designation to Evaxion Biotech’s personalized cancer therapy
FDA grants fast track designation to Evaxion Biotech’s personalized cancer therapy
Pharmaceutical Business Review
Evaxion Biotech
EVX-01
FDA
fast track
personalized medicine
Flag link:
Lilly's tirzepatide slides into FDA fast lane for obesity, turning up heat on Novo Nordisk's Wegovy
Lilly's tirzepatide slides into FDA fast lane for obesity, turning up heat on Novo Nordisk's Wegovy
Fierce Pharma
Eli Lilly
Novo Nordisk
obesity
FDA
fast track
tirzepatide
Flag link:
11 drugs granted FDA fast track designation in 2022
11 drugs granted FDA fast track designation in 2022
Beckers Hospital Review
FDA
fast track
Agios Pharmaceuticals
CTI BioPharma
Bristol Myers Squibb
Nobel Biocare
BioXcel Therapeutics
Mycovia Pharmaceuticals
Phathom Pharmaceuticals
Mitsubishi Tanabe Pharma
SIGA technologies
Alnylam Pharmaceuticals
Flag link:
Drugmakers are slow to prove medicines that got a fast track to market really work
Drugmakers are slow to prove medicines that got a fast track to market really work
NPR
FDA
drug approvals
accelerated approvals
fast track
cancer
Flag link:
FDA grants fast track designation for Anthos’ cancer associated thrombosis therapy
FDA grants fast track designation for Anthos’ cancer associated thrombosis therapy
Pharmaceutical Business Review
Anthos Therapeutics
Factor XI inhibitor
abelacimab
fast track
FDA
cancer
Flag link:
Pfizer (PFE) Gets Fast Track Designation for NASH Therapy
Pfizer (PFE) Gets Fast Track Designation for NASH Therapy
Yahoo/Zacks.com
Pfizer
NASH
FDA
fast track
ervogastat/clesacostat
Flag link:
Pfizer's NASH Treatment Lands FDA Fast Track Designation
Pfizer's NASH Treatment Lands FDA Fast Track Designation
BioSpace
Pfizer
FDA
NASH
ervogastat/clesacostat
fast track
Flag link:
Pharma company continues its FDA lawsuit spree, this time after agency denies fast-track designation
Pharma company continues its FDA lawsuit spree, this time after agency denies fast-track designation
Endpoints
FDA
Vanda Pharmaceuticals
fast track
tradipitant
Flag link:
FDA grants Prothena fast track designation for Alzheimer’s disease therapy
FDA grants Prothena fast track designation for Alzheimer’s disease therapy
Biopharma Reporter
Prothena
FDA
fast track
Alzheimer's status
PRX012
Flag link:
SwanBio gets FDA Fast Track designation for adrenomyeloneuropathy therapy
SwanBio gets FDA Fast Track designation for adrenomyeloneuropathy therapy
Pharmaceutical Business Review
SwanBio Therapeutics
gene therapy
FDA
fast track
SBT101
AMN
Flag link:
Biogen and Eisai move forward with investigational Alzheimer's therapy
Biogen and Eisai move forward with investigational Alzheimer's therapy
Biopharma Reporter
Biogen
Eisai
lecanemab
Alzheimer's disease
fast track
FDA
Flag link:
Biogen-Eisai's potential Aduhelm sequel drug granted speedy review by FDA
Biogen-Eisai's potential Aduhelm sequel drug granted speedy review by FDA
Fierce Biotech
Biogen
Eisai
lecanemab
FDA
Aduhelm
fast track
Alzheimer's disease
Flag link:
BioNTech Bags Fast-Track Status for Melanoma Treatment
BioNTech Bags Fast-Track Status for Melanoma Treatment
BioSpace
BioNTech
melanoma
BNT111
FDA
fast track
Flag link:
Vor's cancer cell therapy gets on FDA fast track ahead of 2022 data drop
Vor's cancer cell therapy gets on FDA fast track ahead of 2022 data drop
Fierce Biotech
Vor Biopharma
JNJ
cell therapy
FDA
fast track
Flag link:
Boehringer, Lilly’s Jardiance ties to match AZ’s Farxiga with heart failure label
Boehringer, Lilly’s Jardiance ties to match AZ’s Farxiga with heart failure label
Pharmaforum
Boehringer Ingelheim
Eli Lilly
Jardiance
FDA
heart failure
fast track
Flag link:

Pages